Chittagong Medical College
Clinical trials sponsored by Chittagong Medical College, explained in plain language.
-
New hope for acute heart failure? drug trial aims to ease symptoms and save lives
Disease control Not yet recruitingThis study tests a drug called levosimendan in people hospitalized with severe acute heart failure. About 332 adults will either receive the drug or standard care. The goal is to see if levosimendan improves breathing and overall heart function better than usual treatments, while…
Phase: PHASE2, PHASE3 • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for dialysis patients: drug targets debilitating itch
Symptom relief Not yet recruitingThis study tests whether the drug difelikefalin can reduce severe itching in people with advanced kidney disease who are on dialysis. About 106 adults will receive either the drug or a placebo during their dialysis sessions for 6 weeks. The main goal is to see if itching scores i…
Phase: NA • Sponsor: Chittagong Medical College • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC